MEDICINE INVEST AS
Operating
Allmennlegevirksomhet og alt som faller naturlig inn under dette.
Konsulenttjenester innen medisinsk relatert virksomhet, drift og
utvikling av egen og andre selskapers løsninger. Investering i andre
virksomheter, herunder aksjer og andeler. Kjøp og salg, samt utleie av
eiendommer. Deltagelse i andre selskap med lignende virksomhet.
Allmennlegetjeneste.
Organization
- CEO
- RB
- Chairman of the board
- RB
- Years since formation
- 8 years
- since May 23, 2018
- Type
- Limited company
- VAT registered
- No
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 30
- 1 share class
- Total number of shareholders
- 1
- person
Financials
- Total operating income 2025
- 4,781,388
- NOK
- Annual total result 2025
- 1,281,775
- NOK
- Total equity 2025
- 2,940,444
- NOK
Last update: Jun 29, 2026
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
RB | Managing Director/CEO | - |
Board
| Name | Role | Shares |
|---|---|---|
RB | Chairman | - |
MB | Board Member | - |
Others
| Name | Role | Shares |
|---|---|---|
| Accountant | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
BR | - | 100 % directly |
Last update: Jan 15, 2024
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
BR | Ordinary shares | 30 | 100 % |
Shares owned by the MEDICINE INVEST AS
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
K Under liquidation | Ordinary shares | 10 | 10 % |
| Class B shares | 15,000 | 0.55 % | |
| Ordinary shares | 208 | < 0.01 % | |
| Ordinary shares | 112 | < 0.01 % | |
| Ordinary shares | 60 | < 0.01 % | |
| Ordinary shares | 500 | < 0.01 % | |
| Ordinary shares | 181 | < 0.01 % | |
| Ordinary shares | 291 | < 0.01 % | |
| Ordinary shares | 73 | < 0.01 % |
Last update: Sep 25, 2026
Financials
in NOK
Summary
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total operating income | 4,781,388 | 3,629,406 | 1,312,745 | 4,230,860 | 3,461,061 |
Annual Total Result | 1,281,775 | 549,703 | 36,923 | 882,362 | 598,656 |
Total assets | 3,736,402 | 2,232,105 | 1,465,335 | 2,109,485 | 1,244,031 |
Total liabilities | 795,959 | 473,435 | 255,354 | 725,720 | 582,628 |
Total equity | 2,940,444 | 1,758,669 | 1,209,982 | 1,383,765 | 661,403 |
P&L
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total operating income | 4,781,388 | 3,629,406 | 1,312,745 | 4,230,860 | 3,461,061 |
Total operating costs | 3,893,326 | 2,939,516 | 1,194,819 | 2,985,830 | 2,700,776 |
Operating result | 888,062 | 689,890 | 117,926 | 1,245,030 | 760,285 |
Financial income/costs | 580,583 | 11,492 | -52,217 | -88,387 | 9,582 |
Profit before tax | 1,468,645 | 701,383 | 65,710 | 1,156,643 | 769,867 |
Total tax & extraordinary income/cost | 186,870 | 151,680 | 28,787 | 274,281 | 171,211 |
Annual Total Result | 1,281,775 | 549,703 | 36,923 | 882,362 | 598,656 |
Balance overview
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total fixed assets | 84,461 | 49,461 | 42,331 | 100,000 | 12,744 |
Total current assets | 3,651,942 | 2,182,644 | 1,423,004 | 2,009,485 | 1,231,287 |
Total assets | 3,736,402 | 2,232,105 | 1,465,335 | 2,109,485 | 1,244,031 |
Short term debt | 795,959 | 473,435 | 254,784 | 725,720 | 582,628 |
Long term debt | 0 | 0 | 570 | 0 | 0 |
Total liabilities | 795,959 | 473,435 | 255,354 | 725,720 | 582,628 |
Contributed capital | 30,000 | 30,000 | 30,000 | 30,000 | 30,000 |
Retained earnings | 2,910,444 | 1,728,669 | 1,179,982 | 1,353,765 | 631,403 |
Total equity | 2,940,444 | 1,758,669 | 1,209,982 | 1,383,765 | 661,403 |
Total equity and liabilities | 3,736,402 | 2,232,105 | 1,465,335 | 2,109,485 | 1,244,031 |
Classification
21st company classification
BETA
Small company
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification